Gossamer Bio, Inc.
Status: Publicly traded
Direct answer
Gossamer Bio, Inc. is publicly traded on NASDAQ under the ticker GOSS.
Gossamer Bio, Inc. operates as a U.S.-based, clinical-stage biopharmaceutical company. Its primary objective is to discover, acquire, advance, and market novel therapeutic solutions, specifically addressing conditions within immunology, inflammatory diseases, and oncology. The company's pipeline highlights several key drug candidates: GB002: An inhaled small molecule designed to inhibit platelet-derived growth...
Can you invest in Gossamer Bio, Inc.?
Yes. Gossamer Bio, Inc. is publicly traded on NASDAQ under the ticker GOSS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Gossamer Bio, Inc.
Detailed equity research is provided by MarketSnap.